TWO SIGMA INVESTMENTS, LP - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 93 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,609,617
-46.1%
336,308
-10.7%
0.02%
-42.3%
Q2 2023$10,398,184
+46.9%
376,473
+22.4%
0.03%
+30.0%
Q1 2023$7,077,100
+31.9%
307,700
-37.5%
0.02%
+17.6%
Q4 2022$5,367,338
+159.2%
491,965
+100.2%
0.02%
+142.9%
Q3 2022$2,071,000
-17.1%
245,705
-22.2%
0.01%
-12.5%
Q2 2022$2,497,000
-63.5%
315,644
+9.4%
0.01%
-60.0%
Q1 2022$6,832,000
+610.9%
288,518
+926.8%
0.02%
+900.0%
Q4 2021$961,000
+120.4%
28,100
+14.2%
0.00%
+100.0%
Q3 2021$436,000
-86.8%
24,600
-66.5%
0.00%
-85.7%
Q2 2021$3,293,000
+52.2%
73,377
-12.1%
0.01%
+16.7%
Q1 2021$2,163,000
-31.4%
83,516
-46.6%
0.01%
-33.3%
Q4 2020$3,152,000
-26.8%
156,366
-29.0%
0.01%
-40.0%
Q3 2020$4,305,000
-15.9%
220,203
-24.1%
0.02%
-40.0%
Q2 2020$5,121,000
+561.6%
289,978
+164.5%
0.02%
+316.7%
Q1 2020$774,000
-46.1%
109,623
-46.2%
0.01%
+50.0%
Q4 2019$1,437,000
+141.9%
203,884
+312.5%
0.00%
+100.0%
Q3 2019$594,000
-59.8%
49,421
-59.5%
0.00%
-60.0%
Q2 2019$1,479,000
+156.3%
122,124
+166.2%
0.01%
+150.0%
Q1 2019$577,000
+49.9%
45,877
-19.8%
0.00%0.0%
Q4 2018$385,000
-74.1%
57,178
-60.4%
0.00%
-50.0%
Q3 2018$1,487,000
+24.6%
144,519
-18.6%
0.00%0.0%
Q2 2018$1,193,000
+323.0%
177,479
+441.1%
0.00%
+300.0%
Q1 2018$282,000
-76.5%
32,800
-43.2%
0.00%
-75.0%
Q4 2017$1,202,00057,7760.00%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 2,449,183$67,646,43421.00%
COWEN AND COMPANY, LLC 1,657,551$45,781,5583.80%
Kynam Capital Management, LP 975,298$26,937,7313.70%
BVF INC/IL 3,775,900$104,290,3582.91%
RTW INVESTMENTS, LP 5,415,514$149,576,4972.85%
Cormorant Asset Management, LP 1,500,000$41,430,0002.32%
Ghost Tree Capital, LLC 225,000$6,214,5002.05%
683 Capital Management, LLC 814,000$22,482,6801.62%
Perceptive Advisors 1,469,761$40,594,7991.18%
Artia Global Partners LP 112,340$3,102,8311.07%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders